Enoxaparin
Concept
Vocabulary Service
Overview
subject area of
-
A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients Academic Article
-
A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis Academic Article
-
A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease Academic Article
-
A Synthetic Pentasaccharide for the Prevention of Deep-Vein Thrombosis Academic Article
-
A Synthetic Pentasaccharide for the Prevention of Deep-Vein Thrombosis after Total Hip Replacement Academic Article
-
A critical appraisal of bleeding events reported in venous thromboembolism prevention trials of patients undergoing hip and knee arthroplasty Academic Article
-
A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgery Academic Article
-
A dose-finding study with TAK-442, an oral factor Xa inhibitor, in patients undergoing elective total knee replacement surgery Academic Article
-
A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery. Academic Article
-
A non-interventional comparison of rivaroxaban with standard of care for thromboprophylaxis after major orthopaedic surgery in 17,701 patients with propensity score adjustment Academic Article
-
A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma. Academic Article
-
A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma. Academic Article
-
A prospective cohort study comparing achieved anti-factor Xa peak levels in pregnant and non-pregnant patients receiving therapeutic-dose low-molecular-weight heparin Academic Article
-
A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT) Academic Article
-
A simple, readily available method for risk stratification of patients with unstable angina and non-ST elevation myocardial infarction Academic Article
-
Abelacimab for Prevention of Venous Thromboembolism Academic Article
-
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 Academic Article
-
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors Academic Article
-
Anti-PF4/heparin antibody formation postorthopedic surgery thromboprophylaxis: the role of non-drug risk factors and evidence for a stoichiometry-based model of immunization Academic Article
-
Anticoagulant Effect at the Time of Epidural Catheter Removal in Patients Receiving Twice-daily or Once-daily Low-molecular-weight Heparin and Continuous Epidural Analgesia after Orthopedic Surgery Academic Article
-
Anticoagulants in acute coronary syndromes Academic Article
-
Antithrombotic Therapy With Fondaparinux in Relation to Interventional Management Strategy in Patients With ST- and Non–ST-Segment Elevation Acute Coronary Syndromes Academic Article
-
Anti–platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin Academic Article
-
Apixaban versus Enoxaparin for Thromboprophylaxis after Hip Replacement Academic Article
-
Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients Academic Article
-
Apixaban versus Enoxaparin in Medically Ill Patients Academic Article
-
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial Academic Article
-
Aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in orthopaedic trauma patients: A patient-centered randomized controlled trial Academic Article
-
Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery Academic Article
-
BAY 59-7939: an oral, direct Factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study Academic Article
-
Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty Academic Article
-
Bridging therapy in patients on long-term oral anticoagulants who require surgery: the Prospective Peri-operative Enoxaparin Cohort Trial (PROSPECT) Academic Article
-
Brief Communication: Preoperative Anticoagulant Activity after Bridging Low-Molecular-Weight Heparin for Temporary Interruption of Warfarin Academic Article
-
Can we differentiate the low-molecular-weight heparins? Academic Article
-
Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial Academic Article
-
Ciraparantag for enoxaparin reversal: Adding to the evidence Academic Article
-
Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 in Africa: Early Insights from the Democratic Republic of the Congo Academic Article
-
Clinical presentation and course of bleeding events in patients with venous thromboembolism, treated with apixaban or enoxaparin and warfarin Academic Article
-
Clinical trials of deep vein thrombosis prophylaxis in medical patients Academic Article
-
Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - A direct and selective antagonist Academic Article
-
Comparison Of The Relative Efficacy And Safety Of Low Molecular Weight Heparin And Unfractionated Heparin For The Treatment Of Venous Thrombosis Conference Paper
-
Comparison of Effectiveness of Enoxaparin Versus Unfractionated Heparin to Reduce Silent and Clinically Apparent Acute Myocardial Infarction in Patients Presenting With Non–ST-Segment Elevation Acute Coronary Syndrome Academic Article
-
Comparison of Fatal or Irreversible Events With Extended‐Duration Betrixaban Versus Standard Dose Enoxaparin in Acutely Ill Medical Patients: An APEX Trial Substudy Academic Article
-
Comparison of Fondaparinux and Enoxaparin in Acute Coronary Syndromes Academic Article
-
Comparison of the Non-Specific Binding of Unfractionated Heparin and Low Molecular Weight Heparin (Enoxaparin) to Plasma Proteins Academic Article
-
Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the organization to assess strategies in acute ischemic syndromes (OASIS)-5 trial Academic Article
-
Correlation of Plasma Coagulation Parameters With Thromboprophylaxis, Patient Characteristics, and Outcome in the MEDENOX Study Academic Article
-
Cost prediction models for the comparison of two groups Academic Article
-
Cost-effectiveness of enoxaparin versus warfarin prophylaxis against deep-vein thrombosis after total hip replacement. Academic Article
-
Country specific cost comparisons from multinational clinical trials using empirical Bayesian shrinkage estimation: the Canadian ASSENT-3 economic analysis Academic Article
-
Dabigatran etexilate for prevention of venous thromboembolism Academic Article
-
Darexaban (YM150) versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a randomised phase IIb dose confirmation study (ONYX-3) Academic Article
-
Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)–5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non–ST-segment elevation acute coronary syndromes Academic Article
-
Differences in the safety profiles of two low-molecular-weight heparins Academic Article
-
Dose Capping Enoxaparin Is Unjustified and Denies Patients With Acute Coronary Syndromes a Potentially Effective Treatment Academic Article
-
Dosing Practices and Risk Factors for Bleeding in Patients Receiving Enoxaparin for the Treatment of an Acute Coronary Syndrome Academic Article
-
ESSENCE trial results: breaking new ground. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events. Academic Article
-
Early time courses of recurrent thromboembolism and bleeding during apixaban or enoxaparin/warfarin therapy Academic Article
-
Economic Evaluation of the MEDENOX Trial: A Canadian Perspective Academic Article
-
Economic analyses of venous thromboembolism prevention strategies in hospitalized patients: a systematic review Academic Article
-
Economic assessment of low-molecular-weight heparin (enoxaparin) versus unfractionated heparin in acute coronary syndrome patients: results from the ESSENCE randomized trial. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q wave Coronary Events [unstable angina or non-Q-wave myocardial infarction]. Academic Article
-
Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial Academic Article
-
Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty Academic Article
-
Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis Academic Article
-
Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Treated With Glycoprotein IIb/IIIa Inhibitors or Thienopyridines Academic Article
-
Efficacy and Safety of Fondaparinux Versus Enoxaparin in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention Academic Article
-
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19 Academic Article
-
Efficacy and safety of enoxaparin versus
unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicentre trial with venographic assessment Academic Article
-
Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial Infarction Academic Article
-
Enoxaparin Use in the Neonatal Intensive Care Unit: Experience Over 8 Years Academic Article
-
Enoxaparin Versus Dabigatran or Rivaroxaban for Thromboprophylaxis After Hip or Knee Arthroplasty Academic Article
-
Enoxaparin for neonatal thrombosis: A call for a higher dose for neonates Academic Article
-
Enoxaparin plus Compression Stockings Compared with Compression Stockings Alone in the Prevention of Venous Thromboembolism after Elective Neurosurgery Academic Article
-
Enoxaparin versus Unfractionated Heparin in ST-Elevation Myocardial Infarction Academic Article
-
Enoxaparin, a low molecular weight heparin, inhibits platelet-dependent prothrombinase assembly and activity by factor-Xa neutralization. Academic Article
-
Extended-Duration Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients With Recently Reduced Mobility Academic Article
-
Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: Methodology for the EXCLAIM study Academic Article
-
Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis Academic Article
-
Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolism Academic Article
-
Feasibility and safety of enoxaparin whole milligram dosing in premature and term neonates Academic Article
-
Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Elective Major Knee Surgery Academic Article
-
Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture Surgery Academic Article
-
Fondaparinux Reduces Long-term Risk of Venous Thromboembolism After Surgery for Hip Fractur Academic Article
-
Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: Outcomes and treatment effect across different levels of risk Academic Article
-
Fondaparinux in the treatment of acute coronary syndromes: evidence from OASIS 5 and 6 Academic Article
-
Fondaparinux versus Enoxaparin in non–ST-elevation acute coronary syndromes: Short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial Academic Article
-
Fondaparinux versus enoxaparin for prevention of venous thromboembolism Academic Article
-
Fondaparinux vs Enoxaparin for the Prevention of Venous Thromboembolism in Major Orthopedic Surgery<subtitle>A Meta-analysis of 4 Randomized Double-blind Studies</subtitle> Academic Article
-
Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin Academic Article
-
Idrabiotaparinux treatment for venous thromboembolism Academic Article
-
Impact of age on the efficacy and safety of extended-duration thromboprophylaxis in medical patients Academic Article
-
Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction Academic Article
-
Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes Academic Article
-
In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation Academic Article
-
Influence of Renal Function on the Efficacy and Safety of Fondaparinux Relative to Enoxaparin in Non–ST-Segment Elevation Acute Coronary Syndromes Academic Article
-
Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes Academic Article
-
Less menorrhagia for women with VTE Academic Article
-
Letter to the editor Academic Article
-
Low Molecular Weight Heparin Administered once versus twice Daily in Patients with Venous Thromboembolism Academic Article
-
Low molecular weight heparins in the treatment of unstable angina. Academic Article
-
Low-Molecular-Weight Heparin as an Adjunct to Thrombolysis in ST Elevation Myocardial Infarction Academic Article
-
Low-Molecular-Weight Heparins Academic Article
-
Low-molecular-weight heparins in non-ST-segment elevation ischemia: the ESSENCE trial. Efficacy and Safety of Subcutaneous Enoxaparin versus intravenous unfractionated heparin, in non-Q-wave Coronary Events. Academic Article
-
Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting Academic Article
-
Management of Anticoagulation Therapy in Patients With Thromboembolism in the Context of Renal Dysfunction Academic Article
-
Management of acute coronary syndromes with low molecular weight heparin: TIMI 11A and 11B. Academic Article
-
Management of unstable angina and myocardial infarction Academic Article
-
Mandatory contrast-enhanced venography to detect deep-vein thrombosis (DVT) in studies of DVT prophylaxis: upsides and downsides Academic Article
-
Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo Academic Article
-
Meta-Analysis: Low-Molecular-Weight Heparin and Bleeding in Patients with Severe Renal Insufficiency Academic Article
-
Milvexian for the Prevention of Venous Thromboembolism Academic Article
-
Minimizing costs for treating deep vein thrombosis: the role for fondaparinux Academic Article
-
Natural history of arterial and venous thrombosis in children treated with low molecular weight heparin: a longitudinal study by ultrasound1 Academic Article
-
Optimizing Prophylaxis of Venous Thromboembolism Academic Article
-
Oral Apixaban for the Treatment of Acute Venous Thromboembolism Academic Article
-
Oral Rivaroxaban for Symptomatic Venous Thromboembolism Academic Article
-
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism Academic Article
-
Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial Academic Article
-
Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement Academic Article
-
Overview of the clinical results of pentasaccharide in major orthopedic surgery. Academic Article
-
Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial Academic Article
-
Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison Academic Article
-
Preoperative Enoxaparin Versus Postoperative Semuloparin Thromboprophylaxis in Major Abdominal Surgery Academic Article
-
Preventing thrombosis: update of first-line therapy in the management of non-ST segment elevation acute coronary syndromes. Academic Article
-
Prevention of venous thromboembolism in medical patients with enoxaparin Academic Article
-
Prevention of venous thromboembolism with an oral factor Xa inhibitor, YM150, after total hip arthroplasty. A dose finding study (ONYX-2) Academic Article
-
Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease∗∗∗∗A list of participating ESSENCE Study Group investigators may be found in N Engl J Med 1997;337:447–52. Academic Article
-
Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes Academic Article
-
Reversal of anti-thrombin activity using protamine sulfate. Experience in a neonate with a 10-fold overdose of enoxaparin Academic Article
-
Review of enoxaparin and its clinical applications in venous and arterial thromboembolism Academic Article
-
Risk Factors for Venous Thromboembolism in Hospitalized Patients With Acute Medical Illness Academic Article
-
Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty Academic Article
-
Rivaroxaban for thromboprophylaxis after orthopaedic surgery: Pooled analysis of two studies Academic Article
-
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty Academic Article
-
Rivaroxaban versus enoxaparin after total knee arthroplasty Academic Article
-
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial Academic Article
-
SR123781A: A New Once-Daily Synthetic Oligosaccharide Anticoagulant for Thromboprophylaxis After Total Hip Replacement Surgery Academic Article
-
Selective factor Xa inhibition for thromboprophylaxis Academic Article
-
Semuloparin for prevention of venous thromboembolism after major orthopedic surgery: results from three randomized clinical trials, SAVE-HIP1, SAVE-HIP2 and SAVE-KNEE Academic Article
-
Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: a case report and literature review Academic Article
-
Superiority of Fondaparinux Over Enoxaparin in Preventing Venous Thromboembolism in Major Orthopedic Surgery Using Different Efficacy End Points Academic Article
-
The Editor's Roundtable: Arterial Thrombosis and Acute Coronary Syndromes Academic Article
-
The Incidence of Symptomatic Venous Thromboembolism After Enoxaparin Prophylaxis in Lower Extremity Arthroplasty Academic Article
-
The Incidence of Symptomatic Venous Thromboembolism During and After Prophylaxis With Enoxaparin<subtitle>A Multi-institutional Cohort Study of Patients Who Underwent Hip or Knee Arthroplasty</subtitle> Conference Paper
-
The United States Food and Drugs Administration Approves a Generic Enoxaparin Academic Article
-
The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: An evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients Academic Article
-
The design of venous thromboembolism prophylaxis trials: Fondaparinux is definitely more effective than enoxaparin in orthopaedic surgery Academic Article
-
The effects of rivaroxaban on the complications of surgery after total hip or knee replacement Academic Article
-
The use of low molecular weight heparin in pediatric patients: A prospective cohort study Academic Article
-
The use of low molecular weight heparins in pediatrics: Two cases that highlight potential risks to patient safety Academic Article
-
Therapy of unstable angina with the low molecular weight heparins Academic Article
-
Thromboprophylaxie hospitalière : doit-on adapter la dose d’énoxaparine au poids des patients ? Academic Article
-
Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials Academic Article
-
Thrombosis prophylaxis in the acutely ill medical patient: insights from the prophylaxis in medical patients with enoxaparin (MEDENOX) trial Academic Article
-
Thrombotic Complications and Thromboprophylaxis Across All Three Stages of Single Ventricle Heart Palliation Academic Article
-
To anticoagulate? Controversy in the management of thrombotic complications of head & neck infections Academic Article
-
Treatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID Trial Academic Article
-
Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: the VENUS study Academic Article
-
Use of a single anti-Xa calibration curve is adequate for monitoring enoxaparin and tinzaparin levels in children Academic Article
-
Use of low molecular mass heparin (enoxaparin) in newborn infants: a prospective cohort study of 62 patients Academic Article
-
Venous Thromboembolism Risk in Ischemic Stroke Patients Receiving Extended-Duration Enoxaparin Prophylaxis: Results From the EXCLAIM Study Academic Article
-
Venous thromboembolism prophylaxis: role of factor xa inhibition by fondaparinux. Academic Article
-
Will the use of low-molecular-weight heparin (enoxaparin) in patients with acute coronary syndrome save costs in Canada? Academic Article
-
XIX congress of the European Society of Cardiology August 24-28, 1997, Stockholm, Sweden. Conference Paper